Successful treatment of pure red cell aplasia with high-dose dexamethasone after ABO-incompatible allogeneic hematopoietic stem cell transplantation

Successful treatment of pure red cell aplasia with high-dose dexamethasone after ABO-incompatible allogeneic hematopoietic stem cell transplantation

The literature reports an incidence of Pure Red Cell Aplasia (PRCA) ranging from 6-30% of all cases of ABO-incompatible HSCT. Although most patients resolve spontaneously after withdrawal immunosuppression, some of them require more aggressive treatment to manage this condition. Keywords: Pure red c...

Full description

Bibliographic Details
Main Authors: Rosario Varela Gómez, Goretti Vázquez Vázquez, Victor Noriega Concepción, Andrea Galego García, Concepción Andón Saavedra
Format: Article
Language:English
Published: Elsevier 2018-03-01
Series:Hematology/Oncology and Stem Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S165838761730119X
id doaj-5a7b2e55e0c545fdbc0c0a7c1662dfca
record_format Article
spelling doaj-5a7b2e55e0c545fdbc0c0a7c1662dfca2020-11-24T23:54:52ZengElsevierHematology/Oncology and Stem Cell Therapy1658-38762018-03-011114446Successful treatment of pure red cell aplasia with high-dose dexamethasone after ABO-incompatible allogeneic hematopoietic stem cell transplantationRosario Varela Gómez0Goretti Vázquez Vázquez1Victor Noriega Concepción2Andrea Galego García3Concepción Andón Saavedra4Departamento de Hematología, Hospital Universitario A Coruña, A Coruña, Spain; Corresponding author at: Haematological Department, Hospital Universitario A Coruña, Xubias de Arriba, 84, A Coruña 15006, Spain. Fax: +34 981178265.Departamento de Hematología, Complejo Hospitalario Universitario de Ferrol, A Coruña, SpainDepartamento de Hematología, Hospital Universitario A Coruña, A Coruña, SpainDepartamento de Hematología, Hospital Universitario A Coruña, A Coruña, SpainDepartamento de Hematología, Hospital Universitario A Coruña, A Coruña, SpainThe literature reports an incidence of Pure Red Cell Aplasia (PRCA) ranging from 6-30% of all cases of ABO-incompatible HSCT. Although most patients resolve spontaneously after withdrawal immunosuppression, some of them require more aggressive treatment to manage this condition. Keywords: Pure red cell aplasia, Aplastic anemia, Hematopoietic stem cell transplantation, Dexamethasonehttp://www.sciencedirect.com/science/article/pii/S165838761730119X
collection DOAJ
language English
format Article
sources DOAJ
author Rosario Varela Gómez
Goretti Vázquez Vázquez
Victor Noriega Concepción
Andrea Galego García
Concepción Andón Saavedra
spellingShingle Rosario Varela Gómez
Goretti Vázquez Vázquez
Victor Noriega Concepción
Andrea Galego García
Concepción Andón Saavedra
Successful treatment of pure red cell aplasia with high-dose dexamethasone after ABO-incompatible allogeneic hematopoietic stem cell transplantation
Hematology/Oncology and Stem Cell Therapy
author_facet Rosario Varela Gómez
Goretti Vázquez Vázquez
Victor Noriega Concepción
Andrea Galego García
Concepción Andón Saavedra
author_sort Rosario Varela Gómez
title Successful treatment of pure red cell aplasia with high-dose dexamethasone after ABO-incompatible allogeneic hematopoietic stem cell transplantation
title_short Successful treatment of pure red cell aplasia with high-dose dexamethasone after ABO-incompatible allogeneic hematopoietic stem cell transplantation
title_full Successful treatment of pure red cell aplasia with high-dose dexamethasone after ABO-incompatible allogeneic hematopoietic stem cell transplantation
title_fullStr Successful treatment of pure red cell aplasia with high-dose dexamethasone after ABO-incompatible allogeneic hematopoietic stem cell transplantation
title_full_unstemmed Successful treatment of pure red cell aplasia with high-dose dexamethasone after ABO-incompatible allogeneic hematopoietic stem cell transplantation
title_sort successful treatment of pure red cell aplasia with high-dose dexamethasone after abo-incompatible allogeneic hematopoietic stem cell transplantation
publisher Elsevier
series Hematology/Oncology and Stem Cell Therapy
issn 1658-3876
publishDate 2018-03-01
description The literature reports an incidence of Pure Red Cell Aplasia (PRCA) ranging from 6-30% of all cases of ABO-incompatible HSCT. Although most patients resolve spontaneously after withdrawal immunosuppression, some of them require more aggressive treatment to manage this condition. Keywords: Pure red cell aplasia, Aplastic anemia, Hematopoietic stem cell transplantation, Dexamethasone
url http://www.sciencedirect.com/science/article/pii/S165838761730119X
work_keys_str_mv AT rosariovarelagomez successfultreatmentofpureredcellaplasiawithhighdosedexamethasoneafteraboincompatibleallogeneichematopoieticstemcelltransplantation
AT gorettivazquezvazquez successfultreatmentofpureredcellaplasiawithhighdosedexamethasoneafteraboincompatibleallogeneichematopoieticstemcelltransplantation
AT victornoriegaconcepcion successfultreatmentofpureredcellaplasiawithhighdosedexamethasoneafteraboincompatibleallogeneichematopoieticstemcelltransplantation
AT andreagalegogarcia successfultreatmentofpureredcellaplasiawithhighdosedexamethasoneafteraboincompatibleallogeneichematopoieticstemcelltransplantation
AT concepcionandonsaavedra successfultreatmentofpureredcellaplasiawithhighdosedexamethasoneafteraboincompatibleallogeneichematopoieticstemcelltransplantation
_version_ 1725464366044676096

Similar Items